Literature DB >> 1443302

Pneumococcal bacteremia in Monroe County, New York.

N M Bennett1, J Buffington, F M LaForce.   

Abstract

OBJECTIVES: Knowledge of the epidemiology of pneumococcal disease is critical for public health planning, evaluation of preventive strategies, and development of immunization recommendations.
METHODS: We studied the incidence and case-fatality rates of pneumococcal bacteremia as a proxy for pneumococcal disease in Monroe County, New York, from 1985 through 1989 by reviewing the laboratory and clinical care records of all cases occurring among residents.
RESULTS: There were 671 cases identified, for an overall yearly rate of 18.8 per 100,000. The rates were highest in the very young, in the very old, and in non-White populations. Age-specific rates were consistently higher in Blacks than in Whites. Predisposing medical conditions were present in 61% of cases. Case-fatality rates were 15% overall, 27% in those with predisposing medical conditions, and approximately 30% in Blacks older than 55 years and Whites older than 65 years.
CONCLUSIONS: This study documents the incidence of and mortality from pneumococcal bacteremia. It supports previous observations that Black populations have an increased risk of invasive pneumococcal infection and suggests that immunization should be considered for Blacks older than 55 years.

Entities:  

Mesh:

Year:  1992        PMID: 1443302      PMCID: PMC1694600          DOI: 10.2105/ajph.82.11.1513

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  14 in total

1.  New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases.

Authors:  G D Fang; M Fine; J Orloff; D Arisumi; V L Yu; W Kapoor; J T Grayston; S P Wang; R Kohler; R R Muder
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

2.  Pneumococcal vaccine--past, present, and future.

Authors:  C V Broome; R F Breiman
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

3.  Nonvalue of sputum culture in the management of lower respiratory tract infections.

Authors:  J R Lentino; D A Lucks
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

4.  The effect of known risk factors on the excess mortality of black adults in the United States.

Authors:  M W Otten; S M Teutsch; D F Williamson; J S Marks
Journal:  JAMA       Date:  1990-02-09       Impact factor: 56.272

5.  Invasive pneumococcal disease in an Alaska native population, 1980 through 1986.

Authors:  M Davidson; C D Schraer; A J Parkinson; J F Campbell; R R Facklam; R B Wainwright; A P Lanier; W L Heyward
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272

6.  Pneumococcal pneumonia. Diagnostic, epidemiologic, therapeutic and prophylactic considerations.

Authors:  R Austrian
Journal:  Chest       Date:  1986-11       Impact factor: 9.410

7.  Misinformation from sputum cultures without microscopic examination.

Authors:  H S Heineman; J K Chawla; W M Lopton
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

8.  Pneumococcal bacteremia in Charleston County, South Carolina.

Authors:  G A Filice; C P Darby; D W Fraser
Journal:  Am J Epidemiol       Date:  1980-12       Impact factor: 4.897

9.  Excess mortality in Harlem.

Authors:  C McCord; H P Freeman
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

10.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

View more
  11 in total

1.  Clonal groups of penicillin-nonsusceptible Streptococcus pneumoniae in Baltimore, Maryland: a population-based, molecular epidemiologic study.

Authors:  M C McEllistrem; M Pass; J A Elliott; C G Whitney; L H Harrison
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Protection of racial/ethnic minority populations during an influenza pandemic.

Authors:  Sonja S Hutchins; Kevin Fiscella; Robert S Levine; Danielle C Ompad; Marian McDonald
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  The association of ethnicity with antibody responses to pneumococcal vaccination among adults with HIV infection.

Authors:  Nancy F Crum-Cianflone; Mollie Roediger; Kathy Huppler Hullsiek; Anuradha Ganesan; Michael Landrum; Amy Weintrob; Brian Agan; Sheila Medina; Jeremy Rahkola; Braden Hale; Edward N Janoff
Journal:  Vaccine       Date:  2010-09-29       Impact factor: 3.641

4.  Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes.

Authors:  E N Janoff; C Fasching; J M Orenstein; J B Rubins; N L Opstad; A P Dalmasso
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  Understanding the reasons for the underuse of pneumococcal vaccination by community-dwelling older African Americans.

Authors:  Linda G Jones; Yan Zhang; Mustafa I Ahmed; O James Ekundayo; Shamima Akhter; Patricia Sawyer; Inmaculada Aban; Richard V Sims; Ali Ahmed
Journal:  J Am Geriatr Soc       Date:  2010-12       Impact factor: 5.562

Review 6.  Epidemiology of pneumococcal infections in the elderly.

Authors:  J C Butler; A Schuchat
Journal:  Drugs Aging       Date:  1999       Impact factor: 3.923

7.  A randomized clinical trial comparing revaccination with pneumococcal conjugate vaccine to polysaccharide vaccine among HIV-infected adults.

Authors:  Nancy F Crum-Cianflone; Katherine Huppler Hullsiek; Mollie Roediger; Anuradha Ganesan; Sugat Patel; Michael L Landrum; Amy Weintrob; Brian K Agan; Sheila Medina; Jeremy Rahkola; Braden R Hale; Edward N Janoff
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 8.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

Review 10.  New vaccines for the prevention of pneumococcal infections.

Authors:  H Käyhty; J Eskola
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.